Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy

Volume: 304, Issue: 1, Pages: 1 - 4
Published: Apr 1, 2003
Abstract
Phospholamban is an endogenous inhibitor of sarcoplasmic reticulum calcium ATPase and plays a prime role in cardiac contractility and relaxation. Phospholamban may be a candidate gene responsible for cardiomyopathy. We investigated genome sequence of phospholamban in patients with cardiomyopathy. PCR-based direct sequence was performed for the promoter region and the whole coding region of phospholamban in 87 hypertrophic, 10 dilated, and 2...
Paper Details
Title
Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy
Published Date
Apr 1, 2003
Volume
304
Issue
1
Pages
1 - 4
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.